Equity Details
Price & Market Data
Price: $1.73
Daily Change: -$0.03 / 1.73%
Daily Range: $1.73 - $1.84
Market Cap: $3,879,220
Daily Volume: 19,079
Performance Metrics
1 Week: -17.22%
1 Month: -16.02%
3 Months: -4.42%
6 Months: -31.89%
1 Year: -85.16%
YTD: -40.55%
About Indaptus Therapeutics, Inc. (INDP)
Comprehensive review of Indaptus Therapeutics, Inc. (INDP). Trading at 1.73, the stock has seen a daily change of -$0.03 / 1.73%. Its market capitalization is 3,879,220. All performance data is available for analysis.
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.